Dalmarco Eduardo Monguilhott, Fröde Tânia Silvia, Medeiros Yara Santos
Department of Clinical Analysis, Center of Health Sciences, Universidade Federal de Santa Catarina, Campus Universitário-Trindade, 88040-970, Florianópolis, SC, Brazil.
Mediators Inflamm. 2002 Oct;11(5):299-306. doi: 10.1080/09629350210000015700.
The model of pleurisy induced by carrageenan exhibits a biphasic response (4 and 48 h) and permits the quantification of exudate, cell migration and certain enzymes such as myeloperoxidase (MPO) and adenosine-deaminase (ADA) that are markers of activated leukocytes.
The present study evaluates whether there exists, in the pleurisy model, a significant inhibition of ADA and MPO enzymes, leukocyte kinetics and other markers of inflammation [nitric oxide (NO) levels, exudation] caused by methotrexate treatment by the intraperitoneal (i.p.) route.
The pleurisy was induced by carrageenan (1%) in mice, and the parameters were analyzed 4 and 48 h after.
After the induction of inflammation (4 h), methotrexate (20 mg/kg, i.p., 24 h before pleurisy induction) inhibited the leukocyte infiltration (p < 0.05), NO levels and MPO activity (p < 0.01), but not ADA activity and fluid leakage (p > 0.05). Regarding the second phase of pleurisy (48 h), methotrexate (40 mg/kg, i.p., 0.5 h before pleurisy induction) inhibited the leukocyte infiltration (p < 0.05), fluid leakage, NO levels (p < 0.01), and ADA and MPO activity (p < 0.05).
These findings support the evidence that the acute administration of methotrexate has an important systemic anti-inflammatory activity in the studied inflammatory model. This effect was due to a significant inhibition on both neutrophil and mononuclear cells, being less marked in relation to exudation 48 h after. In relation to the enzymes studied and to NO levels, the findings support the evidence that methotrexate inhibits both enzymes (MPO and ADA) from leukocytes at the site of injury, thus reflecting the activation of both neutrophils and lymphocytes, respectively. Furthermore, the inhibiting effect on NO in both phases of pleurisy induced by carrageenan (4 and 48 h) indicates that methotrexate acts on constitutive and/or inducible NO synthases by means of different cells of the pleural cavity.
角叉菜胶诱导的胸膜炎模型呈现双相反应(4小时和48小时),并可对渗出液、细胞迁移以及某些酶(如髓过氧化物酶(MPO)和腺苷脱氨酶(ADA),这些是活化白细胞的标志物)进行定量分析。
本研究评估在胸膜炎模型中,腹腔注射甲氨蝶呤治疗是否会对ADA和MPO酶、白细胞动力学以及其他炎症标志物[一氧化氮(NO)水平、渗出]产生显著抑制作用。
用角叉菜胶(1%)诱导小鼠胸膜炎,并在4小时和48小时后分析各项参数。
在炎症诱导后(4小时),甲氨蝶呤(20毫克/千克,腹腔注射,在胸膜炎诱导前24小时)抑制了白细胞浸润(p < 0.05)、NO水平和MPO活性(p < 0.01),但对ADA活性和液体渗漏无抑制作用(p > 0.05)。关于胸膜炎的第二阶段(48小时),甲氨蝶呤(40毫克/千克,腹腔注射,在胸膜炎诱导前0.5小时)抑制了白细胞浸润(p < 0.05)、液体渗漏、NO水平(p < 0.01)以及ADA和MPO活性(p < 0.05)。
这些发现支持了甲氨蝶呤急性给药在该研究炎症模型中具有重要全身抗炎活性的证据。这种作用是由于对中性粒细胞和单核细胞均有显著抑制,在48小时后的渗出方面抑制作用较弱。关于所研究的酶和NO水平,这些发现支持了甲氨蝶呤在损伤部位抑制白细胞中的两种酶(MPO和ADA)的证据,从而分别反映了中性粒细胞和淋巴细胞的活化。此外,角叉菜胶诱导的胸膜炎两个阶段(4小时和48小时)对NO的抑制作用表明,甲氨蝶呤通过胸腔的不同细胞作用于组成型和/或诱导型一氧化氮合酶。